BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 38588567)

  • 1. Opportunistic salpingectomy to decrease the risk of ovarian cancer.
    Werger M; Ardestani SK; Sobel M
    CMAJ; 2024 Jun; 196(22):E765. PubMed ID: 38857930
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent viable ectopic pregnancy in the salpingectomy stump.
    Anwar S; Uppal T
    Australas J Ultrasound Med; 2010 Aug; 13(3):37-40. PubMed ID: 28191089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
    Kotsopoulos J; Narod SA
    Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: A reappraisal.
    Oliver Perez MR; Magriñá J; García AT; Jiménez Lopez JS
    Surg Oncol; 2015 Dec; 24(4):335-44. PubMed ID: 26690823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salpingectomy for ectopic pregnancy reduces ovarian cancer risk-a nationwide study.
    Yen JC; Wu TI; Stone R; Wang TL; Visvanathan K; Chen LY; Hsu MH; Shih IM
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38588567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer risk after salpingectomy for ectopic pregnancy or hydrosalpinx: results of the OCASE nationwide population-based database study.
    van Lieshout LAM; Piek JMJ; Verwijmeren K; Houterman S; Siebers AG; de Hullu JA; Bekkers RLM
    Hum Reprod; 2021 Jan; 36(1):211-218. PubMed ID: 33156914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
    Salvador S; Scott S; Francis JA; Agrawal A; Giede C
    J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian Response and in Vitro Fertilization Outcomes After Salpingectomy: Does Salpingectomy Indication Matter?
    Pereira N; Pryor KP; Voskuilen-Gonzalez A; Lekovich JP; Elias RT; Spandorfer SD; Rosenwaks Z
    J Minim Invasive Gynecol; 2017; 24(3):446-454.e1. PubMed ID: 28069482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
    van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salpingectomy and the Risk of Ovarian Cancer in Ontario.
    Giannakeas V; Murji A; Lipscombe LL; Narod SA; Kotsopoulos J
    JAMA Netw Open; 2023 Aug; 6(8):e2327198. PubMed ID: 37566421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic Salpingectomy for Ovarian Cancer Prevention: A Call for Action.
    Rius M; Carugno J; Abrao MS; Carmona F
    J Am Coll Surg; 2023 Aug; 237(2):376-378. PubMed ID: 37042549
    [No Abstract]   [Full Text] [Related]  

  • 12. Postpartum Opportunistic Salpingectomy Compared With Bilateral Tubal Ligation After Vaginal Delivery for Ovarian Cancer Risk Reduction: A Cost-Effectiveness Analysis.
    Wagar MK; Forlines GL; Moellman N; Carlson A; Matthews M; Williams M
    Obstet Gynecol; 2023 Apr; 141(4):819-827. PubMed ID: 36897130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.
    Fu Z; Brooks MM; Irvin S; Jordan S; Aben KKH; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Brooks-Wilson A; Chang-Claude J; Cook LS; Cramer DW; Cushing-Haugen KL; Doherty JA; Ekici AB; Fasching PA; Fortner RT; Gayther SA; Gentry-Maharaj A; Giles GG; Goode EL; Goodman MT; Harris HR; Hein A; Kaaks R; Kiemeney LA; Köbel M; Kotsopoulos J; Le ND; Lee AW; Matsuo K; McGuire V; McLaughlin JR; Menon U; Milne RL; Moysich KB; Pearce CL; Pike MC; Qin B; Ramus SJ; Riggan MJ; Rothstein JH; Schildkraut JM; Sieh W; Sutphen R; Terry KL; Thompson PJ; Titus L; van Altena AM; White E; Whittemore AS; Wu AH; Zheng W; Ziogas A; Taylor SE; Tang L; Songer T; Wentzensen N; Webb PM; ; Risch HA; Modugno F
    J Natl Cancer Inst; 2023 May; 115(5):539-551. PubMed ID: 36688720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention.
    Hanley GE; Pearce CL; Talhouk A; Kwon JS; Finlayson SJ; McAlpine JN; Huntsman DG; Miller D
    JAMA Netw Open; 2022 Feb; 5(2):e2147343. PubMed ID: 35138400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
    Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.